84 related articles for article (PubMed ID: 12796378)
1. The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome.
Barrans SL; Evans PA; O'Connor SJ; Kendall SJ; Owen RG; Haynes AP; Morgan GJ; Jack AS
Clin Cancer Res; 2003 Jun; 9(6):2133-9. PubMed ID: 12796378
[TBL] [Abstract][Full Text] [Related]
2. The genetic landscape of histologically transformed marginal zone lymphomas.
Li A; Yi H; Deng S; Ruan M; Xu P; Huo Y; Lu H; Shen X; Ouyang B; Cai M; Xu H; Wang Z; Zhang L; Zhu L; Peng Q; Gu Y; Xie J; Wang Y; Dong L; Liu Z; Wang C
Cancer; 2024 Apr; 130(8):1246-1256. PubMed ID: 37941429
[TBL] [Abstract][Full Text] [Related]
3. Diffuse Large B Cell Lymphoma Cell Line U-2946: Model for MCL1 Inhibitor Testing.
Quentmeier H; Drexler HG; Hauer V; MacLeod RA; Pommerenke C; Uphoff CC; Zaborski M; Berglund M; Enblad G; Amini RM
PLoS One; 2016; 11(12):e0167599. PubMed ID: 27907212
[TBL] [Abstract][Full Text] [Related]
4. [CD23 positive, BCL2 rearrangement-negative germinal centre lymphomas].
Menter T; Quintanilla-Martinez L
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):160-163. PubMed ID: 37932478
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL.
Xu-Monette ZY; Li Y; Snyder T; Yu T; Lu T; Tzankov A; Visco C; Bhagat G; Qian W; Dybkaer K; Chiu A; Tam W; Zu Y; Hsi ED; Hagemeister FB; Wang Y; Go H; Ponzoni M; Ferreri AJM; Møller MB; Parsons BM; Fan X; van Krieken JH; Piris MA; Winter JN; Au Q; Kirsch I; Zhang M; Shaughnessy J; Xu B; Young KH
Clin Cancer Res; 2023 Dec; 29(23):4808-4821. PubMed ID: 37728879
[TBL] [Abstract][Full Text] [Related]
6. Analysis of immunophenotypic features in hyaline vascular type Castleman disease.
Chang Y; Ma Y; Chang C; Li W
Diagn Pathol; 2023 Dec; 18(1):132. PubMed ID: 38062501
[TBL] [Abstract][Full Text] [Related]
7. Assessment for 11q and other chromosomal aberrations in large B-cell/high-grade B cell lymphomas of germinal center phenotype lacking BCL2 expression.
Ho CC; Naresh K; Liu Y; Wu Y; Gopal AK; Eckel AM
Cancer Genet; 2024 Mar; 284-285():30-33. PubMed ID: 38520765
[TBL] [Abstract][Full Text] [Related]
8. Mouse Models of Germinal Center Derived B-Cell Lymphomas.
Meyer SN; Koul S; Pasqualucci L
Front Immunol; 2021; 12():710711. PubMed ID: 34456919
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphoma.
Pindzola GM; Razzaghi R; Tavory RN; Nguyen HT; Morris VM; Li M; Agarwal S; Huang B; Okada T; Reinhardt HC; Knittel G; Kashkar H; Young RM; Pittaluga S; Muppidi JR
Blood; 2022 Sep; 140(10):1119-1131. PubMed ID: 35759728
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of regulatory B-cell markers, transforming growth factor β and interleukin-10 as a prognostic factor in diffuse large B-cell lymphoma.
Mishina T; Miyoshi H; Takeuchi M; Miyawaki K; Nakashima K; Yamada K; Moritsubo M; Inoue-Mitsuyama K; Shimasaki Y; Imamoto T; Kawamoto K; Furuta T; Kohno K; Kato K; Akashi K; Ohshima K
Pathol Res Pract; 2024 Feb; 254():155117. PubMed ID: 38262270
[TBL] [Abstract][Full Text] [Related]
11. UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against diffuse large B-cell lymphoma.
Caracciolo D; Polerà N; Belmonte B; Conforti F; Signorelli S; Gulino A; Staropoli N; Tuccillo FM; Bonelli P; Juli G; Grillone K; Ascrizzi S; Cirillo M; Migale L; Ballerini A; Pelizon C; Di Martino MT; Tagliaferri P; Riillo C; Tassone P
Br J Haematol; 2024 Feb; 204(2):555-560. PubMed ID: 37963444
[TBL] [Abstract][Full Text] [Related]
12. Translocation t(14;18) and gain of chromosome 18/BCL2: effects on BCL2 expression and apoptosis in B-cell non-Hodgkin's lymphomas.
Galteland E; Sivertsen EA; Svendsrud DH; Smedshammer L; Kresse SH; Meza-Zepeda LA; Myklebost O; Suo Z; Mu D; Deangelis PM; Stokke T
Leukemia; 2005 Dec; 19(12):2313-23. PubMed ID: 16193090
[TBL] [Abstract][Full Text] [Related]
13. In Vitro Diffuse Large B-Cell Lymphoma Cell Line Models as Tools to Investigate Novel Immunotherapeutic Strategies.
Kubacz M; Kusowska A; Winiarska M; Bobrowicz M
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612228
[TBL] [Abstract][Full Text] [Related]
14. Dose-adjusted EPOCH and rituximab for the treatment of double expressor and double-hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome.
Dodero A; Guidetti A; Marino F; Tucci A; Barretta F; Re A; Balzarotti M; Carniti C; Monfrini C; Chiappella A; Cabras A; Facchetti F; Pennisi M; Rahal D; Monti V; Devizzi L; Miceli R; Cocito F; Farina L; Ricci F; Rossi G; Carlo-Stella C; Corradini P
Haematologica; 2022 May; 107(5):1153-1162. PubMed ID: 34289655
[TBL] [Abstract][Full Text] [Related]
15. Role of MYC and BCL2 expression in a cohort of 43 patients with DLBCL: a retrospective study.
Khan UT; Kelly M; Dodd J; Fergiani S; Hammer B; Smith J; Arumainathan A; Atherton M; Carter A; Racu-Amoasii I; Kalakonda N; Pettitt A; Menon G
J Clin Pathol; 2021 Dec; 74(12):816-818. PubMed ID: 33380460
[No Abstract] [Full Text] [Related]
16. Molecular Genetics of Relapsed Diffuse Large B-Cell Lymphoma: Insight into Mechanisms of Therapy Resistance.
Berendsen MR; Stevens WBC; van den Brand M; van Krieken JH; Scheijen B
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33260693
[TBL] [Abstract][Full Text] [Related]
17. A Great Mimicker in Thoracic Spine: Spinal Double Expressor Lymphoma.
Mufti M; Nawab K; Mohammad R
J Hematol; 2018 Sep; 7(3):116-119. PubMed ID: 32300424
[TBL] [Abstract][Full Text] [Related]
18. Infiltrative Rash Secondary to Leukemic-Phase Diffuse Large B-Cell Lymphoma With t(14;18), CDKN2A and MLL Deletion.
Sheng IY; Treaba DO; Bishop KD
J Hematol; 2017 Oct; 6(4):90-95. PubMed ID: 32300400
[TBL] [Abstract][Full Text] [Related]
19. Spinal lesion as the first manifestation of high-grade B-cell lymphoma, with
Ye Y; Zhang W; Zhao S; Jiang L; Liu W; Long Y; Wan Y
Int J Clin Exp Pathol; 2017; 10(8):8858-8862. PubMed ID: 31966752
[TBL] [Abstract][Full Text] [Related]
20. Tumor Microenvironment in Diffuse Large B-Cell Lymphoma: Role and Prognosis.
Cioroianu AI; Stinga PI; Sticlaru L; Cioplea MD; Nichita L; Popp C; Staniceanu F
Anal Cell Pathol (Amst); 2019; 2019():8586354. PubMed ID: 31934533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
